333 related articles for article (PubMed ID: 15963354)
1. Therapeutic role of coenzyme Q(10) in Parkinson's disease.
Shults CW
Pharmacol Ther; 2005 Jul; 107(1):120-30. PubMed ID: 15963354
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial abnormalities and oxidative imbalance in neurodegenerative disease.
Ogawa O; Zhu X; Perry G; Smith MA
Sci Aging Knowledge Environ; 2002 Oct; 2002(41):pe16. PubMed ID: 14603007
[TBL] [Abstract][Full Text] [Related]
3. Bioenergetic approaches for neuroprotection in Parkinson's disease.
Beal MF
Ann Neurol; 2003; 53 Suppl 3():S39-47; discussion S47-8. PubMed ID: 12666097
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
Storch A; Jost WH; Vieregge P; Spiegel J; Greulich W; Durner J; Müller T; Kupsch A; Henningsen H; Oertel WH; Fuchs G; Kuhn W; Niklowitz P; Koch R; Herting B; Reichmann H;
Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q treatment of neurodegenerative diseases of aging.
Galpern WR; Cudkowicz ME
Mitochondrion; 2007 Jun; 7 Suppl():S146-53. PubMed ID: 17485247
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection for Parkinson's disease.
LeWitt PA
J Neural Transm Suppl; 2006; (71):113-22. PubMed ID: 17447422
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.
Henchcliffe C; Beal MF
Nat Clin Pract Neurol; 2008 Nov; 4(11):600-9. PubMed ID: 18978800
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.
Arduíno DM; Esteves AR; Cardoso SM; Oliveira CR
Neurochem Int; 2009 Sep; 55(5):341-8. PubMed ID: 19375464
[TBL] [Abstract][Full Text] [Related]
9. Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10.
Somayajulu M; McCarthy S; Hung M; Sikorska M; Borowy-Borowski H; Pandey S
Neurobiol Dis; 2005 Apr; 18(3):618-27. PubMed ID: 15755687
[TBL] [Abstract][Full Text] [Related]
10. Environmental toxins and Parkinson's disease: putative roles of impaired electron transport chain and oxidative stress.
Abdulwahid Arif I; Ahmad Khan H
Toxicol Ind Health; 2010 Mar; 26(2):121-8. PubMed ID: 20207656
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria, oxidative stress, and antioxidant defences.
Lenaz G; Bovina C; Formiggini G; Parenti Castelli G
Acta Biochim Pol; 1999; 46(1):1-21. PubMed ID: 10453977
[TBL] [Abstract][Full Text] [Related]
12. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.
Isobe C; Abe T; Terayama Y
Neurosci Lett; 2010 Jan; 469(1):159-63. PubMed ID: 19944739
[TBL] [Abstract][Full Text] [Related]
13. Ubiquinone (coenzyme Q10) and complex I in mitochondrial oxidative disorder of Parkinson's disease.
Ebadi M; Muralikrishnan D; Pellett LJ; Murphy T; Drees K
Proc West Pharmacol Soc; 2000; 43():55-63. PubMed ID: 11056957
[No Abstract] [Full Text] [Related]
14. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
16. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.
Cai X; Jia H; Liu Z; Hou B; Luo C; Feng Z; Li W; Liu J
J Neurosci Res; 2008 Dec; 86(16):3622-34. PubMed ID: 18709653
[TBL] [Abstract][Full Text] [Related]
17. The coenzyme Q10 status of the brain regions of Parkinson's disease patients.
Hargreaves IP; Lane A; Sleiman PM
Neurosci Lett; 2008 Dec; 447(1):17-9. PubMed ID: 18840506
[TBL] [Abstract][Full Text] [Related]
18. Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease.
Isobe C; Murata T; Sato C; Terayama Y
J Clin Neurosci; 2007 Apr; 14(4):340-3. PubMed ID: 16647853
[TBL] [Abstract][Full Text] [Related]
19. The essentiality of coenzyme Q for bioenergetics and clinical medicine.
Lenaz G; Fato R; Degli Esposti M; Rugolo M; Parenti Castelli G
Drugs Exp Clin Res; 1985; 11(8):547-56. PubMed ID: 3015541
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and physiological aspects of ubiquinone function.
Pobezhimova TP; Voinikov VK
Membr Cell Biol; 2000; 13(5):595-602. PubMed ID: 10987383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
